Tag
- Pfizer's paxlovid reduces the risk of COVID-19 by 26% 2022-11-07
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- 1200 cases were newly prescribed by Junshi Biologic for mild... 2022-10-24
- Twenty-five COVID-19 Vaccines In China Enter Stages Of Clini... 2022-06-09
- Pfizer to Increase Production Capacity of COVID-19 Oral Drug... 2022-06-08
- Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant S... 2022-05-17
- As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid ... 2022-05-16
- Survey On Corona Deaths By Country 2022-05-09
- COVID-19 Drug Remdesivir Approved for Infants And Young Chil... 2022-04-28
- Roche's Q1 Performance Increases by 10%, And Total Revenue f... 2022-04-26
Market Analysis
- Insufficient Downstream Demand Leads to Weak DMF Market Prices May-20,2026
- The negative spread has widened, with acrylic acid prices continuously falling and showing weakness domestically in China May-20,2026
- Weak Consumption Leads to Decline in ABS Prices in Mid-May in China May-20,2026
- Short-term correction in lithium carbonate, medium to long-term logic remains unchanged May-19,2026
- Geopolitical Deadlock and Tightening Inventories Drive Crude Oil Prices Higher on Friday May-19,2026